| Literature DB >> 28088217 |
Jian Yang1, Qi Jia1, Dongyu Peng1, Wei Wan1, Nanzhe Zhong1, Yan Lou1, Xiaopan Cai1, Zhipeng Wu1, Chenglong Zhao1, Xinghai Yang2, Jianru Xiao3.
Abstract
BACKGROUND: The surgical treatment of upper cervical spine metastases are controversial up to now. By summarizing and analyzing the clinical data of the upper cervical spine involved metastases treated surgically in our center, we mainly aimed to investigate the surgical decisions and outcomes so as to provide more references for the clinical treatment of this special and complex spine metastasis.Entities:
Keywords: Metastasis; Prognosis; Reconstruction; Surgery; Upper cervical spine
Mesh:
Year: 2017 PMID: 28088217 PMCID: PMC5237490 DOI: 10.1186/s12957-016-1085-0
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Clinical data of 39 atlantoaxil metastases treated surgically in this study
| Case | Age/sex | Primary tumor | Growth | Symptom | Level | Operation | Complication | Adjuvant therapy | Frankel | Follow-up (mos) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approach | Resection | Reconstruction | Pre-operation | Post-operation | Survival status | |||||||||
| 1 | 55/F | Lung | Rapid | Pain | C1 | HCA + P | Piecemeal | OPCF | None | C | R | E/E | 5 | Death |
| 2 | 55/M | Lung | Rapid | Pain | C1–2 | HCA + P | Piecemeal | OPCF | None | — | C | D/E | 33 | Death |
| 3 | 65/M | Lung | Rapid | Pain | C2–3 | HCA + P | Subtotal | OPCF | None | — | R | E/E | 7 | Death |
| 4 | 51/M | Lung | Rapid | Pain | C1–3 | P | Subtotal | OPCF | None | — | R + C | D/E | 10 | Death |
| 5 | 70/M | Lung | Rapid | Pain | C1–2 | HCA + P | Piecemeal | OPCF | None | R | E/E | 13 | Death | |
| 6 | 60/F | Lung | Rapid | Pain | C1 | P | Piecemeal | OPCF | None | C | R | E/E | 29 | Alive |
| 7 | 62/M | Lung | Rapid | Pain, dysphagia | C1 | HCA + P | Piecemeal | OPCF | None | — | R + C | E/E | 12 | Death |
| 8 | 46/M | Lung | Rapid | Pain | C2 | HCA + P | Piecemeal | OPCF | Wound dehiscence dysphagia dysphonia | — | R + C | D/E | 24 | Death |
| 9 | 42/M | Lung | Rapid | Pain | C2 | HCA + P | Piecemeal | OPCF | None | C | R | E/E | 18 | Death |
| 10 | 45/M | Lung | Rapid | Pain | C2 | HCA + P | Piecemeal | OPCF | None | — | — | E/E | 6 | Death |
| 11 | 60/F | Lung | Rapid | Pain | C2–3 | HCA | Piecemeal | BCT | None | — | E/E | 9 | Death | |
| 12 | 62/F | Lung | Rapid | Pain | C2–3 | P | Piecemeal | C1–4 | None | — | C | E/E | 19 | Alive |
| 13 | 50/M | Lung | Rapid | Pain | C2,4 | P | Piecemeal | C2–4 | None | C | R | E/E | 6 | Death |
| 14 | 52/M | Lung | Rapid | Pain | C2–4 | P | Piecemeal | C2–4 | None | — | C | E/E | 10 | Alive |
| 15 | 72/M | Lung | Rapid | Pain | C2 | HCA + P | Piecemeal | BGT + C1–4 | None | — | E/E | 17 | Alive | |
| 16 | 61/M | Nasopharyngeal | Rapid | Pain | C1 | HCA + P | Piecemeal | OPCF | None | — | R | E/E | 71 | Death |
| 17 | 56/M | Nasopharyngeal | Rapid | Pain | C1–2 | P | Subtotal | OPCF | None | — | R | E/E | 26 | Death |
| 18 | 63/M | Nasopharyngeal | Rapid | Pain | C1–3 | P | Subtotal | OPCF | None | — | E/E | 15 | Alive | |
| 19 | 55/M | Nasopharyngeal | Rapid | None | C2 | HCA + P | Piecemeal | OPCF | None | — | R | E/E | 10 | Death |
| 20 | 27/M | Hepatic | Rapid | Pain | C2 | HCA + P | Piecemeal | OPCF | None | — | R | E/E | 36 | Alive |
| 21 | 64/F | Hepatic | Rapid | Pain | C2 | HCA + P | Piecemeal | OPCF | None | — | R | E/E | 39 | Death |
| 22 | 56/M | Hepatic | Rapid | Pain, dysphagia | C2 | HCA + P | Piecemeal | OPCF | None | — | — | D/D | 3 | Death |
| 23 | 54/F | Thyroid | Slow | Pain, numbness of the upper limbs | C2–4 | P | Piecemeal | C1–5 | None | — | R | E/E | 78 | Alive |
| 24 | 70/M | Thyroid | Slow | Pain | C2 | HCA + P | Piecemeal | BGT + OPCF | None | — | D/E | 12 | Death | |
| 25 | 45/F | Thyroid | Slow | Pain, dysphagia dysphonia | C1–2 | HCA + P | Piecemeal | OPCF | None | — | R | E/E | 60 | Death |
| 26 | 45/M | Renal | Moderate | Pain | C1 | P | Piecemeal | OPCF | None | C | C | E/E | 13 | Death |
| 27 | 58/M | Renal | Moderate | Pain | C1–2 | HCA + P | Piecemeal | OPCF | None | R | R | E/E | 18 | Death |
| 28 | 59/M | Renal | Moderate | Pain, numbness of the upper limbs | C1–4 | P + HCAa | Subtotal | OPCF | None | R + C | R | E/E | 6 | Death |
| 29 | 60/M | Osteosarcoma | Rapid | Weakness of the lower limbs | C2–4 | P | Subtotal | C2–5 | Hematoma, wound dehiscence | — | — | C/C | 6 | Death |
| 30 | 8/M | Osteosarcoma | Rapid | Pain | C1–2 | P | Subtotal | OPCF | None | C | — | E/E | 4 | Death |
| 31 | 37/M | Osteosarcoma | Rapid | Pain, weakness of the upper limbs | C1–2 | HCA + P | Piecemeal | OPCF | None | — | C | E/E | 36 | Death |
| 32# | 77/M | Prostatic | Slow | Pain | C2 | HCA + P | Piecemeal | BCT + OPCF | Died of airway obstruction | — | — | D | 0 | Death |
| 33 | 62/M | Prostatic | Slow | Pain | C1–2 | P | Piecemeal | OPCF | None | — | R | D/E | 22 | Death |
| 34 | 51/F | Breast | Slow | Pain | C1–2 | HCA + P | Piecemeal | OPCF | Dysphagia, dysphonia | — | R | D/E | 72 | Death |
| 35 | 49/F | Breast | Slow | Pain | C2–4 | HCA + P | Piecemeal | BCT + C2–5 | None | R + C | — | E/E | 24 | Alive |
| 36 | 62/F | Basaloma | Slow | Pain | C2–3 | HCA + P | Piecemeal | BGT + OPCF | None | — | R | E/E | 10 | Alive |
| 37 | 80/M | Colon | Moderate | Pain | C1–2 | HCA + P | Piecemeal | OPCF | Dyspnea | — | E/E | 10 | Death | |
| 38 | 69/M | Bladder | Rapid | Pain | C2–3 | HCA + P | Piecemeal | BCT + OPCF | None | — | — | D/D | 3 | Death |
| 39 | 30/M | Unknown | Rapid | Pain | C1–2 | HCA + P | Piecemeal | OPCF | None | — | R + C | D/E | 47 | Death |
HCA high anterior cervical approach, P posterior, OPCF occipitalcervical fusion, BCT bone cement and titanium, BGT bone graft and titanium, R radiotherapy, C chemotherapy
#Patient died of airway obstruction after operation
aThe posterior approach was conducted first
Fig. 1Pathologies proportion of the 39 atlantoaxial metastases
Survival time of different Tomita scoring groups
| Tomita scoring | Cases | Mean survival (mos) | Median survival (mos) |
|---|---|---|---|
| 2–3 points | 7 | 29 | 60 |
| 4–5 points | 9 | 33 | 47 |
| 6–7 points | 11a | 17 | 18 |
| 8–10 points | 11 | 13 | 7 |
aThe dead patient was excluded from this group
Fig. 2a Kaplan–Meier curve of 38 atlantoaxial metastases showed that the overall survival rates at 1, 2, and 3 years after surgery were 58.5, 40, and 28.3%, respectively. b Kaplan–Meier curves of different growth groups in atlantoaxial metastases showed that the median survival rates of slow, moderate, and rapid growth group were 60, 18, and 10 months, respectively
Fig. 3The survival time of different Tomita scoring groups
Fig. 4One case with C2 metastasis (thyroid cancer) suffered serious pain for half a year. a The posterior occipitalcervical fixation was conducted only when he was first adopted into another hospital. b He came to our center for unrelieved continuous neck pain. We performed the tumor resection through an anterior-posterior approach, followed by the spine reconstruction without complication. c The last follow-up at 11 months without recurrence and discomfort